c="glycine" 1:3 1:3||t="medication"||cui="C0017890"||tot="Glycine"||ns="-1000"
c="amino acid position 910" 1:8 1:11||t="medication"||cui="C0002520"||tot="Amino Acids"||ns="-861"
c="Ehlers-Danlos syndrome type IV" 1:25 1:28||t="problem"||cui="C0268338"||tot="Ehlers-Danlos Syndrome, Type IV"||ns="-1000"
c="Ehlers-Danlos syndrome type IV" 2:6 2:9||t="problem"||cui="C0268338"||tot="Ehlers-Danlos Syndrome, Type IV"||ns="-1000"
c="cyanogen bromide fragment 9" 2:21 2:24||t="test"||cui="C0010511"||tot="Cyanogen Bromide"||ns="-861"
c="Sequence analysis" 2:51 2:52||t="test"||cui="C0162801"||tot="Sequence Analysis"||ns="-1000"
c="glycine 910" 2:66 2:67||t="medication"||cui="C0017890"||tot="Glycine"||ns="-861"
c="valine" 2:69 2:69||t="medication"||cui="C0042285"||tot="Valine"||ns="-1000"
c="genomic DNA" 2:81 2:82||t="test"||cui="C0012854"||tot="DNA"||ns="-861"
